Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
Status:
Not yet recruiting
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The investigator study evaluate the effect of different lipid lowering agents on the
progression of diabetic retinopathy and other reduction of cardiovascular risk of diabetic
patients